European regulators have given their backing to a new eco-friendly inhaler that could help curb health care’s climate impact.

A panel of the European medicines regulator has recommended approving an eco-friendly version of AstraZeneca's inhaler for ...

For many years, the standard treatment for asthma was an inhaler with a medication called albuterol. Only if that wasn’t enough would additional medicines be added. If symptoms became especially ...

One of the most widely-used asthma and breathing treatments for over 20 years is being taken off the shelves in 2024, potentially leaving patients, healthcare providers and insurers scrambling ...

Glaxo Smith Kline (GSK) announced in May that Flovent HFA, a metered-dose inhaler, as well as Flovent Diskus, a dry powder inhaler, would be discontinued as of Dec. 31, 2023. Experts weigh in.

March 15, 2024 Asthma meds have become shockingly unaffordable − but relief may be on the way The price of an inhaler has jumped from about $10 to nearly $100 over the last 15 years.

People with asthma know how important inhalers are, but they are also a source of planet-warming pollution. A new study looks at that impact and what can be done.

Warning for asthma patients regarding inhalers 00:26. Flovent, a popular steroid inhaler used to treat and control asthma symptoms in children and adults, is being discontinued next week as its ...

Active ingredient: Ciclesonide 80 µg/inhalation, 160 µg/inhalation; metered-dose inhaler. Indication: Maintenance treatment of asthma as prophylactic therapy in patients > 12 years of age.

The Allergy & Asthma Network (AAN) applauds corporate decisions to cap inhaler prices at $35. Two caps are set to take effect June 1. The AAN hopes other drugs will also see price caps.